Saturday, October 25, 2014 Last update: 8:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Correction to Press Release Announcing SK3 Group (OTC Pink: SKTO) Agreement to Merge

Companies mentioned in this article: SK3 Group, Inc.

LOS ANGELES, CA -- (Marketwired) -- 03/04/14 -- Earlier today Alternative Energy Partners, Inc. (OTCBB: AEGY) (OTCQB: AEGY), doing business as PharmaJanes™, and SK3 Group (OTC Pink: SKTO), doing business as Medical Greens™, announced an agreement to merge. That press release contained an error that the companies wish to correct. The release incorrectly stated the previously announced AEGY dividend as 30 million shares, but the companies had previously released that the dividend amount would be 100 million shares. The companies wish to clarify that 100 million shares is the correct number for that dividend that will be accounted for in the merger. All other aspects of today's release remain accurate as stated.

About PharmaJanes

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives. PharmaJanes™ is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.

About SKTO

SK3 is a healthcare logistics and fulfillment consultancy doing business as Medical Greens™ and focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement

The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Contact:

A. Mayor
investors@medicalgreens.com
Investor Relations